Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


European Pharmaceutical Pricing & Reimbursement

21 Oct 2013 - 22 Oct 2013 - London, UK



Bookmark and Share


We are delighted to announce SMi's European Pharmaceutical Pricing & Reimbursement. Now in its 19th year, this event has been one of the oldest market leaders in the pharmaceutical industries calendar for some time.

The agenda aims to bring together experts from key industry personnel from big Pharma, biotech and academia who will thoroughly explain and offer advice on P&R and market access. The conference will focus on European and US markets including country specific case studies proving strategic insight into how a wide range of complex issues can be readily adapted to.

This conference provides the most comprehensive up to date centre of information with reimbursement evidence inproduct development; Impact of HTA in different markets and international based price referencing.

KEY REASONS TO ATTEND

Understand how value based pricing will affect the U.Ks pricing market and what to expect

Discuss key market access strategies with a range of case studies including those currently being developed successfully with orphan drugs

Evaluate current strategies with the new NICE network reforms

See the establishment of the pan-European HTA network and its current effects

Develop future cross sector market access strategies


Register online here: www.smi-online.co.uk/2013europricing26.asp

Alternatively, contact: Jonathan Collins on +44 (0)20 7827 6734 or email: jcollins@smi-online.co.uk 

Academic & Group discounts available



Further information
Scientific News
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!